Jul 13, 2022· Comment from Parenteral Drug Association· FDA-2022-D-0705-0010
See attached comments from the Parenteral Drug Association. These Comments were also submitted on 15 March to the European Medicines Agency.
FDANonrulemakingFDA-2022-D-0705
Q9(R1) Quality Risk Management; International Council for Harmonisation; Draft Guidance for Industry; Availability
RIN
—
Last modified
May 4, 2023
Comment window
closed 1474d ago
Parenteral Drug Association filings
1
Activity
Parenteral Drug Association filed 1 comment on this docket between Jul 13, 2022 and Jul 13, 2022. 0 other organizations filed here. The comment window closed 1474d ago.
What Parenteral Drug Association filed (1)
Abstract
OPEN
View on regulations.gov →Co-filers (0)
See everyone who commented →- Parenteral Drug AssociationTHIS ORG1 filing · confidence 97%